Anika Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
ANIK on Nasdaq
Location
32 Wiggins Avenue, Bedford, Massachusetts

There are no Buy or Sell transactions made by insiders since 7/8/2023

Anika Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cheryl R. Blanchard President, CEO, Director, Director $6.16 M Mar 15, 2024
Michael L. Levitz EVP, CFO, Treasurer $1.76 M Mar 15, 2024
David Colleran EVP, General Counsel, Corp Sec $1.35 M Mar 15, 2024
Stephen D. Griffin EVP, CFO and Treasurer $993 K Jun 3, 2024
Thomas Finnerty EVP, Human Resources $590 K Mar 9, 2022
Jeffery S. Thompson Director $588 K Jun 14, 2023
Anne Nunes SVP, Chief Operations Officer $567 K Mar 15, 2024
Glenn R. Larsen Director $565 K Jun 14, 2023
Susan Vogt Director $564 K Jun 14, 2023
John B. Henneman III Director $558 K Jun 14, 2023
Stephen Richard Director $520 K Jun 14, 2023
Sheryl L. Conley Director $422 K Jun 14, 2023
Gary P. Fischetti Director $404 K Jun 14, 2023
Raymond J. Land Director $226 K Jun 16, 2021
James Loerop EVP Business Development $182 K Jul 8, 2021
William R. Jellison Director $81.7 K Jun 3, 2024
Joseph H. Capper Director $12.1 K Jun 3, 2024

Recent Insider Transactions by Companies or Individuals for Anika Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership